Unmasking snake venom of bothrops leucurus: Purification and pharmacological and structural characterization of new PL A2 Bleu TX-III

Fábio André Marangoni, Luis Alberto Ponce-Soto, Sergio Marangoni, Elen Cristina Teizem Landucci

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

16 Citas (Scopus)

Resumen

Bleu TX-III was isolated from Bothrops leucurus snake venom on one-step analytical chromatography reverse phase HPLC, was homogeneous on SDS-PAGE, and was confirmed by Q-Tof Ultima API ESI/MS (TOF MS mode) mass spectrometry in 14243.8 Da. Multiple alignments of Bleu TX-III show high degree of homology with basic PLA2 myotoxins from other Bothrops venoms. Our studies on local and systemic myotoxicity "in vivo" reveal that Bleu TX-III is myotoxin with local but not systemic action due to the decrease in the plasmatic CK levels when Bleu TX-III is administrated by intravenous route in mice (dose 1 and 5 g). And at a dose of 20 g myotoxin behaves like a local and systemic action. Bleu TX-III induced moderate marked paw edema, evidencing the local increase in vascular permeability. The inflammatory events induced in the mice (I.M.) were investigated. The increase in the levels of IL-1, IL-6, and TNF-α was observed in the plasma. It is concluded that Bleu TX-III induces inflammatory events in this model. The enzymatic phospholipid hydrolysis may be relevant to these phenomena. Bothrops leucurus venom is still not extensively explored, and the knowledge of its toxins separately through the study of structure/function will contribute for a better understanding of its action mechanism.

Idioma originalInglés
Número de artículo941467
PublicaciónBioMed Research International
Volumen2013
DOI
EstadoPublicada - 2013
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Unmasking snake venom of bothrops leucurus: Purification and pharmacological and structural characterization of new PL A2 Bleu TX-III'. En conjunto forman una huella única.

Citar esto